Journals / Nöropsikiyatri Arşivi / 2015 / Cilt: 52 - Sayı: 3

Association of Demyelinating and Inflammatory Bowel Diseases: A Case Series and Overview of the Literature

Demiyelinizan Hastalık ve İnflamatuvar Barsak Hastalığı Birlikteliği: Olgu Serisi ve Literatürün Gözden Geçirilmesi

Pages
315–318
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, asymptomatic cerebral white matter lesions may be detected in these have both multiple sclerosis and Crohn's disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neurological complications of inflammatory bowel diseases (i.e., ulcerative colitis and Crohn's disease) can be summarized as a combination of neuromuscular manifestations, cerebrovascular, and demyelinating a family with ulcerative colitis and multiple sclerosis, and two patients who diseases that can be seen in approximately 3% of patients.
📊
Key Findings & Data:Neurological complications of inflammatory bowel diseases (i.e., ulcerative colitis and Crohn's disease) can be summarized as a combination of neuromuscular manifestations, cerebrovascular, and demyelinating a family with ulcerative colitis and multiple sclerosis, and two patients who diseases that can be seen in approximately 3% of patients.
💡
Conclusion & Impact:In addition, asymptomatic cerebral white matter lesions may be detected in these have both multiple sclerosis and Crohn's disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Neurological complications of inflammatory bowel diseases (i.e., ulcerative colitis and Crohn's disease) can be summarized as a combination of neuromuscular manifestations, cerebrovascular, and demyelinating a family with ulcerative colitis and multiple sclerosis, and two patients who diseases that can be seen in approximately 3% of patients. In addition, asymptomatic cerebral white matter lesions may be detected in these have both multiple sclerosis and Crohn's disease.

Özet

Ülseratif kolit (ÜK) ve Crohn hastalığı (CH) gibi inflamatuvar barsak hastalıklarında (İBH) nörolojik tutulum sıklığı %3'tür. Bu hastalarda en sık görülen nörolojik tablolar sırasıyla nöromüsküler, serebrovasküler ve demiyelinizan hastalıklardır. Nörolojik olarak asemptomatik olan olgularda bile nadir olmayarak fokal serebral ak madde lezyonları görülebilmektedir. Otoimmün hastalıkların bazı ailelerde kümelenmesi, ortak genler, ortak çevresel etkilere maruz kalma ya da her ikisinin kombinasyonu ile açıkla nabilir. Bu yazıda CH tanısı ile izlenen ve nöbet geçirdiği için tetkik edilen; fokal serebral ak madde lezyonları saptanan, 1 sene sonra epilepsia parsiyalis kontinua (EPK) tablosuna giren bir hasta, multipl skleroz (MS) ve ülseratif kolitin kümelendiği bir aile ve hem MS hem de CH tanılı iki hasta, literatürdeki bilgiler eşliğinde tartışılarak bildirilecektir.

🔖

Cite This Article

ATMACA, M. M., UZUN, G. A., SHUGAIV, E., KÜRTÜNCÜ, M., ERAKSOY, M. (2015). Association of Demyelinating and Inflammatory Bowel Diseases: A Case Series and Overview of the Literature. Nöropsikiyatri Arşivi, Cilt: 52 - Sayı: 3, 315–318. https://ajindex.com/articles/292373

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immuno- biology. Lancet 2007
  2. [CrossRef] Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and es- tablished and evolving therapies. Lancet 2007
  3. [CrossRef] Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraint- estinal diseases in inflammatory bowel disease: A population-based study. Am J Gastroenterol 2001
  4. [CrossRef] Barcellos LF, Kamdar BB, Ramsay PP, Deloa C, Lincoln RR, Caillier S, Schmidt S, Haines JL, Pericak-Vance MA, Oksenberg JR, Hauser SL. Clustering of auto- immune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 2006
  5. [CrossRef] Geissler A, Andus T, Roth M, Kullmann F, Caesar I, Held P, Gross V, Feuerbach S, Schölmerich J. Focal white-matter lesions in brain of patients with inflamma- tory bowel-disease. Lancet 1995
  6. [CrossRef] Agranoff D, Schon F. Are focal white-matter lesions in patients with inflammatory bowel-disease linked to multiple-sclerosis. Lancet 1995
  7. [CrossRef] Hart PE, Gould SR, MacSweeney JE, Clifton A, Schon F. Brain white-matter lesions in inflammatory bowel disease. Lancet 1998
  8. [CrossRef] Lossos A, River Y, Eliakim A, Steiner I. Neurologıc aspects of inflammatory bowel-disease. Neurology 1995
  9. [CrossRef] Benavente L, Moris G. Neurologic disorders associated with inflammatory bowel disease. Eur J Neurol 2011
  10. [CrossRef] Singh S, Kumar N, Loftus EV Jr, Kane SV. Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics. Inflamm Bowel Dis 2013
  11. [CrossRef] Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, Pritchard ML, Sandborn WJ. Serious infections and mortality in associ- ation with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006
  12. [CrossRef] Nielsen NM, Frisch M, Rostgaard K, Wohlfahrt J, Hjalgrim H, Koch-Henriksen N, Melbye M, Westergaard T. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Den- mark. Mult Scler 2008
  13. [CrossRef] Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 2005
  14. [CrossRef] Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S